Breast cancer: In vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases

Radiology

Volumn 225, Issue 1, 2002, Pages 190-197

  Yeung, David K W ^a   Yang, Wei Tse ^a   Tse, Gary M K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Breast neoplasms; Lymphatic system; Magnetic resonance (MR); MR; Neoplasms; Spectroscopy

Indexed keywords

CHOLINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

EID: 0036789111     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2243011519     Document Type: Article

References (30)

1. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103.
2. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
3. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
4. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197:387-395.
5. Harms SE, Flaming DP. MR imaging of the breast. J Magn Reson Imaging 1993; 3:277-283.
6. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology 1997; 202:833-841.
7. Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994; 4:477-480.
8. den Boer JA, Hoenderop RK, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997; 7:702-715.
9. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997; 3:780-782.
10. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211:101-110.
11. 1H MRS, and perfusion MRI improves specificity in detection of breast malignancy (abstr). In: Proceedings of the Ninth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 2313.
12. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5:303-324.
13. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997; 204:661-666.
14. Cheng LL, Chang IW, Smith BL, Gonzalez RG. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 1998; 135:194-202.
15. Katz-Brull R, Margalit R, Bendel P, Degani H. Choline metabolism in breast cancer: 2H-, 13C- and 31P-NMR studies of cells and tumors. MAGMA 1998; 6:44-52.
16. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998; 8:1191-1197.
17. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998; 209:269-275.
18. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999; 10:159-164.
19. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84:1016-1022.
20. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001; 220: 40-46.
21. Senofsky GM, Moffat FL Jr, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991; 126:1336-1341.
22. Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997; 203: 317-321.
23. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43.
24. van den Boogaart A, van Ormondt D, Pijnappel WWF, de Beer R, Ala-Korpela M. Removal of the water resonance from H-1 magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in signal processing III. Oxford, England: Clarendon, 1994; 175-195.
25. MR User Interface [MRUI] software package. A van den Boogaart, Katholieke Universiteit Leuven, Belgium; available at www.mrui.uab.es/ mrui/mruiHomePage.html. Accessed July 1, 2000.
26. van den Boogaart A, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR. In vivo 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR Biomed 1995; 8:87-93.
27. Lo W, Barry P, Lean C, et al. Fine needle biopsy of human lymph nodes (abstr). In: Proceedings of the Sixth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1998; 1685.
28. Mountford CE, Lean CL, Hancock R, et al. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion Metastasis 1993; 13:57-71.
29. Cheng LL, Lean CL, Bogdanova A, et al. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med 1996; 36:653-658.
30. Star-Lack JM, Adalsteinsson E, Gold GE, Ikeda DM, Spielman DM. Motion correction and lipid suppression for 1H magnetic resonance spectroscopy. Magn Reson Med 2000; 43:325-330.